Evidence map›Paper›PMID 38288387›Full record

ArticleVirus evolution2023

Multiple introductions and country-wide spread of DENV-2 genotype II (Cosmopolitan) in Brazil.

Tiago Gräf, Caroline Do Nascimento Ferreira, Gustavo Barbosa de Lima, Raul Emídio de Lima, Lais Ceschini Machado, Tulio de Lima Campos, Michelle Orane Schemberger, Helisson Faoro, Marcelo Henrique Santos Paiva, Matheus Filgueira Bezerra and 23 more

Open access · goldAbstract read
In one paragraph

Article in Virus evolution, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Emergence of Dengue Virus Serotype 2 Cosmopolitan Genotype in Costa Rica.The American journal of tropical medicine and hygiene · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors at 10 institutions in 2 countries.

Tiago GräfLaboratório de Virologia Molecular, Instituto Carlos Chagas, Fundação Oswaldo Cruz, Curitiba 81350-010, Brazil.ORCID https://orcid.org/0000-0003-4921-7975
Caroline Do Nascimento FerreiraLaboratório de Virologia Molecular, Instituto Carlos Chagas, Fundação Oswaldo Cruz, Curitiba 81350-010, Brazil.
Gustavo Barbosa de LimaNúcleo de Plataformas Tecnológicas (NPT), Instituto Aggeu Magalhães (IAM), FIOCRUZ-Pernambuco, Recife, Pernambuco 50740-465, Brazil.
Raul Emídio de LimaNúcleo de Plataformas Tecnológicas (NPT), Instituto Aggeu Magalhães (IAM), FIOCRUZ-Pernambuco, Recife, Pernambuco 50740-465, Brazil.
Lais Ceschini MachadoDepartamento de Entomologia, Instituto Aggeu Magalhães (IAM)-Fundação Oswaldo Cruz-FIOCRUZ, Recife, Pernambuco 50670-420, Brazil.
Tulio de Lima CamposNúcleo de Bioinformática (NBI), Instituto Aggeu Magalhães (IAM), FIOCRUZ-Pernambuco, Recife, Pernambuco 50740-465, Brazil.
Michelle Orane SchembergerLaboratório de Ciências e Tecnologias Aplicadas em Saúde, Instituto Carlos Chagas, Fundação Oswaldo Cruz, Curitiba 81350-010, Brazil.
Helisson FaoroLaboratório de Ciências e Tecnologias Aplicadas em Saúde, Instituto Carlos Chagas, Fundação Oswaldo Cruz, Curitiba 81350-010, Brazil.
Marcelo Henrique Santos PaivaNúcleo de Ciências da Vida, Universidade Federal de Pernambuco (UFPE), Centro Acadêmico do Agreste-Rodovia BR-104, km 59-Nova Caruaru, Caruaru 55002-970, Brazil.
Matheus Filgueira BezerraDepartamento de Microbiologia, Instituto Aggeu Magalhães (IAM), FIOCRUZ-Pernambuco, Recife, Pernambuco 50740-465, Brazil.
Valdinete NascimentoLaboratório de Ecologia de Doenças Transmissíveis na Amazônia, Instituto Leônidas e Maria Deane, Fiocruz, Manaus 69057-070, Brazil.
Victor SouzaLaboratório de Ecologia de Doenças Transmissíveis na Amazônia, Instituto Leônidas e Maria Deane, Fiocruz, Manaus 69057-070, Brazil.
Fernanda NascimentoLaboratório de Ecologia de Doenças Transmissíveis na Amazônia, Instituto Leônidas e Maria Deane, Fiocruz, Manaus 69057-070, Brazil.
Matilde MejíaLaboratório de Ecologia de Doenças Transmissíveis na Amazônia, Instituto Leônidas e Maria Deane, Fiocruz, Manaus 69057-070, Brazil.
Dejanane SilvaLaboratório de Ecologia de Doenças Transmissíveis na Amazônia, Instituto Leônidas e Maria Deane, Fiocruz, Manaus 69057-070, Brazil.
Yasmin Silva de OliveiraLaboratório de Ecologia de Doenças Transmissíveis na Amazônia, Instituto Leônidas e Maria Deane, Fiocruz, Manaus 69057-070, Brazil.
Luciana GonçalvesLaboratório de Ecologia de Doenças Transmissíveis na Amazônia, Instituto Leônidas e Maria Deane, Fiocruz, Manaus 69057-070, Brazil.
Tatyana Costa Amorim RamosFundação de Vigilância em Saúde do Amazonas-Dra Rosemary Costa Pinto, Manaus, Amazonas 69093-018, Brazil.
Daniel Barros de CastroFundação de Vigilância em Saúde do Amazonas-Dra Rosemary Costa Pinto, Manaus, Amazonas 69093-018, Brazil.ORCID https://orcid.org/0000-0001-5969-544X
Ana Ruth ArcanjoLaboratório Central de Saúde Pública do Amazonas (LACEN-AM), Manaus, Amazonas 69020-040, Brazil.
Herton Augusto Pinheiro DantasLaboratório de Fronteira de Tabatinga (LAFRON-AM), Tabatinga, Amazonas 69640-000, Brazil.
Mayra Marinho PresibellaLaboratório Central de Saúde Pública do Estado do Paraná (LACEN-PR), São José dos Pinhais, Paraná 83060-500, Brazil.
Sandra Bianchini FernandesLaboratório Central de Saúde Pública do Estado de Santa Catarina (LACEN-SC), Florianópolis, Santa Catarina 88010-001, Brazil.
Tatiana Schaffer GregianiniLaboratório Central de Saúde Pública do Rio Grande do Sul (LACEN-RS), Porto Alegre, Rio Grande do Sul 90610-000, Brazil.
Keilla Maria Paz E SilvaLaboratório Central de Saúde Pública de Pernambuco (LACEN-PE), Recife, Pernambuco 50050-210, Brazil.
Claudio Tavares SacchiLaboratorio Estrategico, Instituto Adolfo Lutz (IAL), Sao Paulo 01246-902, Brazil.
Ana Cecília Ribeiro CruzDepartment of Arbovirology and Hemorrhagic Fevers, Evandro Chagas Institute, Health and Environment Surveillance Secretariat, Ministry of Health, Ananindeua, Para 670030-000, Brazil.
Claudia Nunes Duarte Dos SantosLaboratório de Virologia Molecular, Instituto Carlos Chagas, Fundação Oswaldo Cruz, Curitiba 81350-010, Brazil.
Ana Maria Bispo de FilippisLaboratório de Arbovírus e Vírus Hemorrágicos, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-360, Brazil.
Gonzalo BelloLaboratório de Arbovírus e Vírus Hemorrágicos, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-360, Brazil.
Gabriel Luz WallauDepartamento de Entomologia, Instituto Aggeu Magalhães (IAM)-Fundação Oswaldo Cruz-FIOCRUZ, Recife, Pernambuco 50670-420, Brazil.ORCID https://orcid.org/0000-0002-1419-5713
Richard Steiner SalvatoLaboratório Central de Saúde Pública do Rio Grande do Sul (LACEN-RS), Porto Alegre, Rio Grande do Sul 90610-000, Brazil.
Felipe NavecaLaboratório de Ecologia de Doenças Transmissíveis na Amazônia, Instituto Leônidas e Maria Deane, Fiocruz, Manaus 69057-070, Brazil.
Fundação Oswaldo Cruz · BRFundação Carlos Chagas · BRFundação de Medicina Tropical · BRGoverno do Estado do Rio Grande do Sul · BRInstituto de Tecnologia de Pernambuco · BRInstituto Adolfo Lutz · BRMinistério da Saúde · BRSecretaria da Saúde · BRSecretaria de Educação de Pernambuco · BRUniversidade Federal de Pernambuco · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dengue virus serotype 2, genotype Cosmopolitan (DENV-2-GII), is one of the most widespread DENV strains globally. In the USA, DENV-2 epidemics have been dominated by DENV-2 genotype Asian-American (DENV-2-GIII), and the first cases of DENV-2-GII were only described in 2019, in Peru, and in 2021 in Brazil. To gain new information about the circulation of DENV-2-GII in Brazil, we sequenced 237 DENV-2 confirmed cases sampled between March 2021 and March 2023 and revealed that DENV-2-GII is already present in all geographic regions of Brazil. The phylogeographic analysis inferred that DENV-2-GII was introduced at least four times in Brazil, between May 2020 and August 2022, generating multiple clades that spread throughout the country with different success. Despite multiple introductions of DENV-2-GII, analysis of the country-wide laboratory surveillance data showed that the Brazilian dengue epidemic in 2022 was dominated by DENV-1 in most states. We hypothesize that massive circulation of DENV-2-GIII in previous years in Brazil might have created a population immune barrier against symptomatic homotypic reinfections by DENV-2-GII, leading to sustained cryptic circulation in asymptomatic cases and localized outbreaks of this new genotype. In summary, our study stresses the importance of arboviral genomic surveillance to close monitoring and better understanding the potential impact of DENV-2-GII in the coming years.

Indexed as

Brazildengue virus serotype 2genomic surveillancegenotype Cosmopolitanphylogeography

Identifiers

PMID38288387
PMCPMC10824474
OpenAlexW4387116441

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.